Welcome to the Chu Lab!

Our lab is focused on defining the diagnosis, prevention and treatment strategies for respiratory syncytial virus (RSV), influenza, and other respiratory viruses. RSV is the most important cause of viral pneumonia in infants worldwide, for which no vaccine or effective treatment is currently available. The lab is also working to develop neutralizing antibody assays to analyze serum and breast milk and evaluate the role of humoral and cellular immunity in protection against respiratory viruses in pregnant women and infants. The lab has additionally developed sequencing techniques to identify patterns of viral transmission in nosocomial and community-based settings. Using these techniques, our group has described transmission patterns of RSV, rhinovirus, and human metapneumovirus, the epidemiology and adverse birth outcomes associated with respiratory viral pneumonia in pregnant women, and the kinetics of transplacental RSV antibody transfer and decay in infants. 



Our latest endeavor is the Seattle Flu Study- a new major initiative to examine flu and other respiratory viruses and learn how these viruses enter into a city, how they spread, and how they cause outbreaks in certain communities. Learn more on our Research page and at https://seattleflu.org.